New version of NeedleBay to be launched in 2021

Following the evaluation of the major study in medication compliance by Cardiff University School of Healthcare Sciences the company has decided to launch a NEW version of its highly successful NeedleBay medication compliance system.

The new version of NeedleBay which contains four pen needle bays and is based on the trial version of the device used by about 250 patients during the Cardiff University study into medication management and compliance.

The new version of NeedleBay will offer users up to 88%, OVERALL improvement in self-management of their diabetes mediation.

The New NeedleBay will initially be available in the UK and USA.

NeedleBay - the only research proven and patented medication compliance system for those with diabetes